What is the fair value of Olympus Corp (OTC-OLYM.Y) stock?

The current fair value estimate for Olympus Corp (OTC-OLYM.Y) is $15.94. This implies an estimated upside of 24.9% versus the current market price.

Is Olympus Corp (OTC-OLYM.Y) undervalued or overvalued?

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 24.9% versus the current market price.

How is the financial health of Olympus Corp?

The current financial health read for Olympus Corp (OTC-OLYM.Y) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Olympus Corp's next earnings date?

The next earnings date currently listed for Olympus Corp (OTC-OLYM.Y) is November 10, 2026.

Does Olympus Corp (OTC-OLYM.Y) pay dividends?

The latest available data indicates no current dividend yield for Olympus Corp (OTC-OLYM.Y).

What is the P/E ratio for Olympus Corp (OTC-OLYM.Y)?

The current P/E ratio listed for Olympus Corp (OTC-OLYM.Y) is 27.2x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

What is the market capitalization of Olympus Corp?

The current market capitalization listed for Olympus Corp is 13.537 B.

What is the enterprise value of Olympus Corp?

The current enterprise value listed for Olympus Corp is 13.27 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Olympus Corp?

The ticker symbol for Olympus Corp is OTC-OLYM.Y, and the stock is listed on OTC Markets.

Where is Olympus Corp (OTC-OLYM.Y) listed?

Olympus Corp (OTC-OLYM.Y) is listed on OTC Markets.

What is the debt-to-total-capital ratio for Olympus Corp?

The current debt-to-total-capital ratio listed for Olympus Corp is 13.0%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Olympus Corp?

The free float listed for Olympus Corp is 100.0%. Free float helps investors understand how much of the share base is available for public trading.

Olympus Corp (OLYMY) Fair Value & Stock Analysis

Olympus Corp (OLYMY)

Olympus Corp is a Japanese healthcare equipment and supplies company whose operations are represented in the listed security as an American depositary receipt on OTC Markets. Through its subsidiaries, the company develops and sells medical equipment across Japan, the Americas, the Middle East, Asia, and Oceania. Its business is organized into Endoscopic Solutions, Therapeutic Solutions, and Other segments. Olympus’s product range includes gastrointestinal endoscopy systems, GI endotherapy tools, endoscopic ecosystem software and AI-enabled detection and diagnosis products, reprocessing equipment, and related medical services. The company also supplies respiratory, urology, surgical, gastroenterology, and gynecology products. Founded in 1919 and headquartered in Hachioji, Japan, Olympus was previously known as Olympus Optical Co., Ltd. before adopting its current name in 2003.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Overall Financial Health	Dividend Yield	Next Earnings Date	P/E Ratio	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Payout Ratio	Free Cash Flow / Net Income
OTC-OLYM.Y	$15.94	24.9% Upside	Undervalued	Not available	Not available	Good	0.0%	November 10, 2026	27.2x	2.8x	2.0x	13.537 B	13.27 B	13.0%	100.0%	7.2	42.2%	91.2%